Results 231 to 240 of about 92,701 (304)

Dislocation‐Mediated Lattice Distortion and Griffiths Phase Behavior in Melt‐Spun Ni2MnSb Ribbons

Advanced Science, EarlyView.
This figure illustrates how melt‐spinning introduces dislocations into Ni2MnSb Heusler alloys. TEM images reveal local lattice distortions and associated strain fields surrounding dislocations at a representative wheel speed. As wheel speed increases, these distortions promote the formation of ferromagnetic clusters within a paramagnetic matrix ...
Kun Wang, Siying Yu, Qizhong Zhao, Jiale Guo, Minxia Fang, Yichuan Tang, Pengqaing Hu, Yin Zhang, Chao Zhou, Kaiyan Cao, Fanghua Tian, Sen Yang   +11 more
wiley   +1 more source

Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices. [PDF]

JCO Precis Oncol
Evangelist M, Wang B, Butrynski JE, Paschold J, Ward PJ, Waterhouse DM, Jotte RM, Ali K, Richards DA, Konduri K, Melnyk A, Owera RS, Hakimian D, Ghaddar H, Lander EM, Robert NJ, Yori JL, Upadhyay V, Spigel DR, Johnson ML.   +19 more
europepmc   +1 more source

Bias‐Engineered Synthetic Antiferromagnets Hosting Sub‐20 nm Zero‐Field Skyrmions at Room Temperature

Advanced Science, EarlyView.
A fully compensated synthetic antiferromagnet (SAF) multilayer exhibits a uniform state at zero field, without skyrmions. We use a SAF bias system to provide RKKY‐mediated exchange bias to the SAF multilayer, promoting zero‐field skyrmion stabilization and polarity control.
Emily Darwin, Riccardo Tomasello, Reshma Peremadathil Pradeep, Mario Carpentieri, Giovanni Finocchio, Hans J. Hug   +5 more
wiley   +1 more source

Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia. [PDF]

J Clin Oncol
Lanino L, Hunter AM, Gagelmann N, Robin M, Dall'Olio D, Flamigni A, Sala C, Gurnari C, Wang YH, Pleyer L, Xicoy B, Montalban-Bravo G, Shih LY, Alsugair A, Fathima S, Gregorio C, Rollo C, Palomo L, Platzbecker AS, Asti G, Itzykson R, Sallman DA, Fariselli P, Kern W, Garcia-Manero G, Platzbecker U, Solé F, Diez-Campelo M, Maciejewski J, Bejar R, Thol F, Kroger N, Savona M, Fenaux P, Sanz G, Kordasti S, Santini V, Fontenay M, Zeidan AM, Komrokji RS, Haferlach T, Germing U, Castellani G, D'Amico S, Patnaik M, Ieva F, Solary E, Tefferi A, Padron E, Della Porta MG, iCPSS Alliance.   +50 more
europepmc   +1 more source

Baseline IPSS-M vs pretransplant risk downstaging as prognostic determinants in MDS undergoing allogeneic transplantation. [PDF]

Blood Adv
Aguirre LE, Kim HT, Elmariah H, Frumm SM, Kelkar AH, Ho V, Gooptu M, Koreth J, Shapiro RM, Romee R, Nikiforow S, Antin JH, Soiffer RJ, Shimony S, Luskin MR, Garcia JS, Chen EC, Wadleigh M, Winer ES, Stone RM, DeAngelo DJ, Al Ali N, Sallman D, Kuykendall A, Sweet K, Lancet JE, Padron E, Chan O, Xie Z, Cutler CS, Komrokji RS, Stahl M.   +31 more
europepmc   +1 more source

Stratifying survival: the role of social determinants of health on AML outcomes by ELN 2022 criteria. [PDF]

Blood Adv
Shimony S, Wang Y, Cronin A, Walsh TP, Charles A, Slopen N, Cho HL, Stahl M, Bystrom RP, Luskin MR, Abel GA, DeAngelo DJ, Stone RM, Lindsley RC, Hantel A.   +14 more
europepmc   +1 more source

Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis. [PDF]

ESMO Open
Raimondi A, Tinè G, Boige V, De Stefano A, Ballhausen A, Gourgou S, Giuliani F, Stahler A, Randon G, Prisciandaro M, Manca P, Ambrosini M, Fazio R, Mohamed S, Gronchi G, Santabarbara G, Brument E, Alig AHS, Miceli R, Bouche O, Modest DP, Avallone A, Pietrantonio F.   +22 more
europepmc   +1 more source

Molecular Tumor Board-Directed Treatment for Patients with Advanced-Stage Solid Tumors: A Case-Control Real-World Study. [PDF]

Curr Oncol
Ponvilawan B, Bansal D, Modi K, Gustafson B, Douglass L, Buzard B, Roth M, Ward C, Pluard T, Subramanian J.   +9 more
europepmc   +1 more source

Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia. [PDF]

Blood Cancer J
Vetro C, Garibaldi B, Grimaldi F, Chiusolo P, Filì C, Riva C, Cardinali V, Franciosa M, Pilo F, Palmieri R, Esposito L, Menotti D, Perrone S, Mulè A, Alati C, Vigna E, Dargenio M, De Luca G, Sperotto A, Tanasi I, Papayannidis C, Molica M, Minetto P, Battipaglia G, Memoli M, Salutari P, Brunetti L, Todisco E, Lotesoriere I, Isidori A, Palumbo GA, Annunziata M, Gottardi M, Gentile M, Martelli MP, Capelli D, Martino M, Rossi M, Ferrara F, Venditti A, Romani C, Galimberti S, Candoni A, Fianchi L, Pagano L, Marconi G, Lemoli RM, Di Raimondo F, Billio A, Palumbo FE, Pane F, Duminuco A, Guolo F.   +52 more
europepmc   +1 more source